A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition

<p>Abstract</p> <p>Background</p> <p>Epithelial-mesenchymal transition of tubular cells is a widely recognized mechanism that sustains interstitial fibrosis in diabetic nephropathy (DN). The signaling of FGF-2, a growth factor involved in this mechanism, is regulated by...

Full description

Bibliographic Details
Published in:	Journal of Translational Medicine
Main Authors:	Masola Valentina, Onisto Maurizio, Zaza Gianluigi, Lupo Antonio, Gambaro Giovanni
Format:	Article
Language:	English
Published:	BMC 2012-10-01
Subjects:	Diabetic nephropathy Epithelial-mesenchymal transition Fibrosis Heparanase-1 Sulodexide Tubular cells
Online Access:	http://www.translational-medicine.com/content/10/1/213

Similar Items

Sulodexide. Nephroprotective properties and horizons for use in nephrology
by: M. M. Batyushin
Published: (2015-12-01)

Heparanase: A Multitasking Protein Involved in Extracellular Matrix (ECM) Remodeling and Intracellular Events
by: Valentina Masola, et al.
Published: (2018-11-01)

Use of low-dose sulodexide in IgA nephropathy patients on renin–angiotensin system blockades
by: Byeong Yun Yang, et al.
Published: (2012-09-01)

Evaluation of the effectiveness of diabetic nephropathy stage III in patients with type 2 diabetes mellitus therapy with sulodexide
by: V. G. Kadzharyan, et al.
Published: (2013-08-01)

Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathy
by: Baranca Buijsers, et al.
Published: (2023-04-01)

Radiation-Induced Nephropathy in the Murine Model Is Ameliorated by Targeting Heparanase
by: Alexia Abecassis, et al.
Published: (2023-02-01)

Sulodexide – unrealized potential in dermatology
by: Dorota Krasowska, et al.
Published: (2019-03-01)

Place of Sulodexide in the Renoprotektivе Therapy of Patients with Chronic Kidney Disease
by: M. M. Batyushin, et al.
Published: (2012-03-01)

PECULIARITIES OF NEPHROPROTECTIVE EFFECT OF SULODEXIDE IN PATIENTS WITH DIABETIC NEPHROPATHY
by: I. I. Topchiy, et al.
Published: (2017-12-01)

The renoprotective effects of sulodexide
by: Olde Engberink RH, et al.
Published: (2016-03-01)

Efficacy of Trimetazidine and Sulodexide in Patients with Microvascular Angina
by: S. A. Boldueva, et al.
Published: (2020-07-01)

Glycosaminoglycans and fucoidan have a protective effect on experimental glomerulonephritis
by: Baranca Buijsers, et al.
Published: (2023-07-01)

Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2
by: Miriam Gross-Cohen, et al.
Published: (2021-01-01)

Endothelial eNOS deficiency causes podocyte injury through NFAT2 and heparanase in diabetic mice
by: Daisuke Katagiri, et al.
Published: (2024-11-01)

Heparanase-1: From Cancer Biology to a Future Antiviral Target
by: Nadjet Lebsir, et al.
Published: (2023-01-01)

Sulodexide as pharmacotherapy for protection of endothelium and suppression of thrombosis in COVID-19
by: A. M. Melkumyants, et al.
Published: (2022-01-01)

Heparanase Modulates Chromatin Accessibility
by: Honglian Li, et al.
Published: (2023-03-01)

Monitoring the effectiveness of the natural anticoagulant sulodexide in pregnant women with autoimmune hyperthyroidism on the background of hyperhomocysteinemia
by: A.Yu. Scherbakov, et al.
Published: (2017-04-01)

Sulodexide Prevents Hyperglycemia-Induced Endothelial Dysfunction and Oxidative Stress in Porcine Retinal Arterioles
by: Alice Dauth, et al.
Published: (2023-02-01)

Effect of glycosoaminoglycans on the clinical course of diabetic nephropathy at the stage of microalbuminuria in patients with type 2 diabetes mellitus
by: Iya Vladimirovna Semenova, et al.
Published: (2010-06-01)

Comprehensive management application of sulodexide on proteinuria: 2 case reports
by: Li Zhou, et al.
Published: (2025-02-01)

Sulodexide Slows Down the Senescence of Aortic Endothelial Cells Exposed to Serum from Patients with Peripheral Artery Diseases
by: Patrycja Sosińska-Zawierucha, et al.
Published: (2018-03-01)

Advances in sulodexide-based long-term anticoagulation for a myasthenia gravis patient with giant thymoma
by: Zhou Liu, et al.
Published: (2025-02-01)

Sulodexide improves vascular permeability via glycocalyx remodelling in endothelial cells during sepsis
by: Jiayun Ying, et al.
Published: (2023-08-01)

Heparanase2 inhibits the growth of gallbladder cancer by regulating the VEGF/VEGFR pathway
by: Dengyi Cao, et al.
Published: (2025-10-01)

A Novel Drug Candidate for Sepsis Targeting Heparanase by Inhibiting Cytokine Storm
by: Danyang Wang, et al.
Published: (2024-08-01)

Heparanase Expression Propagates Liver Damage in CCL4-Induced Mouse Model
by: Xiaowen Cheng, et al.
Published: (2022-06-01)

Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury.
by: Valentina Masola, et al.
Published: (2016-01-01)

Regulation of Heparanase in Diabetes-Associated Pancreatic Carcinoma
by: Rachel Goldberg, et al.
Published: (2019-12-01)

Correlation between heparanase gene polymorphism and susceptibility to endometrial cancer
by: Hanyu Cao, et al.
Published: (2020-10-01)

In silico investigation of heparanase-correlated genes in breast cancer subtypes
by: Carina Mucciolo Melo, et al.
Published: (2020-10-01)

Protective role of N-acetylcysteine and Sulodexide on endothelial cells exposed on patients’ serum after SARS-CoV-2 infection
by: Justyna Rajewska-Tabor, et al.
Published: (2023-12-01)

Role of heparanase in pulmonary hypertension
by: Lin-Jun Wang, et al.
Published: (2023-08-01)

Sulodexide inhibits neointimal hyperplasia of arteriovenous fistulas in rats through inactivation of YAP
by: LI Yaxin, et al.
Published: (2024-06-01)

Icariin inhibits epithelial mesenchymal transition of renal tubular epithelial cells via regulating the miR-122-5p/FOXP2 axis in diabetic nephropathy rats
by: Li Zang, et al.
Published: (2022-02-01)

Heparanase-1 activities in the development of laser induced choroidal neovascularization
by: Bao-Ke Hou, et al.
Published: (2013-04-01)

Heparanase in cancer progression: Structure, substrate recognition and therapeutic potential
by: Fengyan Yuan, et al.
Published: (2022-09-01)

Expression and Clinical Significance of Heparanase and Ki-67 in Non-small Cell Lung Cancer
by: Xiaoming QIU, et al.
Published: (2009-07-01)

Role of heparanase 2 (Hpa2) in gastric cancer
by: Jingjing Liu, et al.
Published: (2021-09-01)

Heparanase contributes to psoriatic lesions through crosstalk with IL-17 pathway
by: Chengyao Zhu, et al.
Published: (2023-01-01)